Literature DB >> 16951834

[Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease].

Fábio Vilas-Boas1, Gilson S Feitosa, Milena B P Soares, Augusto Mota, Joel Alves Pinho-Filho, Augusto José Gonçalves Almeida, Marcus Vinicius Andrade, Heitor G Carvalho, Adriano Dourado-Oliveira, Ricardo Ribeiro-dos-Santos.   

Abstract

OBJECTIVE: To evaluate early effects of bone marrow cell transplantation to the myocardium of patients with heart failure (CHF) due to Chagas disease.
METHODS: We studied 28 patients (mean age 52.2 +/- 9.9), of whom 24 were male. Despite optimized treatment, 25 patients were in NYHA class III and three patients, in NYHA class IV. The procedure consisted of aspiration of 50 mL of bone marrow, separation of the mononuclear fraction, and intracoronary injection. Effects on left ventricle ejection fraction (LVEF), distance walked in the six-minute walking test, quality-of-life, NYHA class, arrhythmogenic and biochemical parameters, were all evaluated.
RESULTS: There were no complications directly related to the procedure. Baseline left ventricular ejection fraction was 20.1 +/- 6.8%, and 60 days after transplantation it increased to 23.0 +/- 9.0%, p = 0.02. Significant improvements were observed in the NYHA class (3.1 +/- 0.3 to 1.8 +/- 0.5; p < 0.0001); quality-of-life (50.9 +/- 11.7 to 21.8 +/- 13.4; p < 0.0001); and distance walked in six minutes (355 +/- 136 m to 443 +/- 110 m; p = 0,003). The number of ventricular premature beats in 24 hours tended to increase (5,322 +/- 4,977 to 7,441 +/- 7,955; p = 0,062), but without increase in ventricular tachycardia episodes (61 +/- 127 to 54 +/- 127; p = 0.27).
CONCLUSION: Our data demonstrate for the first time that intracoronary injection of bone marrow mononuclear cells is feasible and suggest that it may be potentially safe and effective in patients with CHF due to Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951834     DOI: 10.1590/s0066-782x2006001500014

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  17 in total

1.  Cardiac function in dogs with chronic Chagas cardiomyopathy undergoing autologous stem cell transplantation into the coronary arteries.

Authors:  Marlos G Sousa; Daniel Paulino-Junior; João P E Pascon; Gláucia B Pereira-Neto; Roberta Carareto; Tatiana Champion; Aparecido A Camacho
Journal:  Can Vet J       Date:  2011-08       Impact factor: 1.008

Review 2.  Role of autoantibodies in the physiopathology of Chagas' disease.

Authors:  Emiliano Horacio Medei; José Hamilton Matheus Nascimento; Roberto Coury Pedrosa; Antônio Carlos Campos de Carvalho
Journal:  Arq Bras Cardiol       Date:  2008-10       Impact factor: 2.000

3.  Benefit of stem cells and skeletal myoblast cells in dilated cardiomyopathies.

Authors:  Luiz César Guarita-Souza; Júlio César Francisco; Rossana Simeoni; Jose Rocha Faria-Neto; Katherine Athayde Teixeira de Carvalho
Journal:  World J Cardiol       Date:  2011-03-26

Review 4.  Bone marrow-derived cell therapy in chagasic cardiac disease: a review of pre-clinical and clinical results.

Authors:  Antonio Carlos Campos de Carvalho; Adriana Bastos Carvalho; Debora Bastos Mello; Regina Coeli Dos Santos Goldenberg
Journal:  Cardiovasc Diagn Ther       Date:  2012-09

5.  Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model.

Authors:  Regina C S Goldenberg; Linda A Jelicks; Fabio S A Fortes; Louis M Weiss; Leonardo L Rocha; Dazhi Zhao; Antonio Campos de Carvalho; David C Spray; Herbert B Tanowitz
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

Review 6.  Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).

Authors:  Herbert B Tanowitz; Fabiana S Machado; Linda A Jelicks; Jamshid Shirani; Antonio C Campos de Carvalho; David C Spray; Stephen M Factor; Louis V Kirchhoff; Louis M Weiss
Journal:  Prog Cardiovasc Dis       Date:  2009 May-Jun       Impact factor: 8.194

7.  Stem cell therapy for the treatment of parasitic infections: is it far away?

Authors:  Yan Zhang; Jing-Yi Mi; Yong-Jun Rui; Yong-Liang Xu; Wei Wang
Journal:  Parasitol Res       Date:  2013-11-26       Impact factor: 2.289

8.  Development of bioartificial myocardium using stem cells and nanobiotechnology templates.

Authors:  Juan Carlos Chachques
Journal:  Cardiol Res Pract       Date:  2010-12-29       Impact factor: 1.866

Review 9.  Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy.

Authors:  Claudio A Muratore; Adrian Baranchuk
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

10.  Therapy of chagas disease: implications for levels of prevention.

Authors:  Sergio Sosa-Estani; Lisandro Colantonio; Elsa Leonor Segura
Journal:  J Trop Med       Date:  2012-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.